Skip to main content

Day: June 8, 2020

Bavarian Nordic Announces Topline Results from Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine

COPENHAGEN, Denmark, June 8, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today topline results from the the first-in-human trial of MVA-BN® WEV, a prophylactic vaccine candidate against three equine encephalitis viruses (western, eastern and Venezuelan), for which there are currently no preventative vaccines available.The Phase 1 trial, funded by the United States Department of Defense’s (DOD) Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) was designed to evaluate the safety, tolerability and immunogenicity of MVA-BN WEV in 45 healthy adults in three treatment groups receiving different doses of the vaccine. All subjects were revaccinated after four weeks.Data...

Continue reading

Bavarian Nordic offentliggør toplinjeresultater fra fase 1-forsøg med vaccine mod hesteencephalit virus

KØBENHAVN, Danmark, 8. juni 2020 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag toplinjeresultater fra det første forsøg i mennesker med den forebyggende vaccinekandidat MVA-BN® WEV mod tre typer af hesteencephalit virus (vestlig, østlig og venezuelansk), mod hvilke der ikke findes vacciner i dag.Fase 1-forsøget, der er finansieret af det amerikanske forsvar, United States Department of Defense’s (DOD) Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical), var udformet til at evaluere sikkerheden, tolerabiliteten og immunogeniciteten af MVA-BN WEV i 45 raske voksne i tre grupper, der blev vaccineret med forskellige doser af vaccinen. Forsøgspersonerne blev revaccineret efter...

Continue reading

Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe disease

Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe diseaseVirtual scientific session June 16, 2020, 8:00-9:00am ET/2:00-3:00pm CETAvalglucosidase alfa receives FDA Breakthrough Therapy designationPARIS – June 8, 2020 – Sanofi will host a virtual scientific session to present data from the Phase 3 COMET trial of investigational enzyme replacement therapy (ERT) avalglucosidase alfa in patients with late-onset Pompe disease (LOPD).  The session, open to healthcare professionals and members of the media, will include a data presentation by Jordi Diaz-Manera, M.D., Ph.D., Professor of Neuromuscular Disorders, Translational Medicine and Genetics at the John Walton Muscular Dystrophy Research Center, Newcastle University, UK, and Professor of Neuromuscular Diseases, Translational Medicine and Genetics...

Continue reading

Sanofi va présenter les résultats de phase III de l’avalglucosidase alpha chez des patients atteints de la forme tardive de la maladie de Pompe             

Sanofi va présenter les résultats de phase III de l’avalglucosidase alpha chez des patients atteints de la forme tardive de la maladie de Pompe                                                                                                                                                           Session scientifique virtuelle le 16 juin 2020, 8 h 00 – 9 h 00 ET / 14 h 00 -15 h 00 CETL’avalglucosidase alpha reçoit la désignation de thérapie révolutionnaire par la FDAPARIS – Le 8 juin 2020 – Sanofi annonce la tenue d’une session scientifique virtuelle pour présenter les données de l’essai de phase III COMET consacré à l’avalglucosidase alpha, son enzymothérapie substitutive expérimentale pour le traitement de la forme tardive de la maladie de Pompe. Réservée aux professionnels de santé et à la presse médicale, cette session comprendra...

Continue reading

LEXIBOOK : OBTENTION D’UN PRET GARANTI PAR L’ETAT DE 2.18 M€ AUPRES DE SES PARTENAIRES BANCAIRES.

                                             Les Ulis, le 8 juin 2020LEXIBOOK : OBTENTION D’UN PRET GARANTI PAR L’ETAT DE 2.18 M€ AUPRES DE SES PARTENAIRES BANCAIRES.Afin de permettre au Groupe de traverser sereinement la crise du Covid-19 et d’assurer son développement en profitant de la reprise économique post-confinement, Lexibook a sollicité auprès de ses partenaires bancaires un Prêt garanti par l’Etat de 2.18 M€.L’ensemble des partenaires bancaires a validé la stratégie et le plan présentés par le Groupe. La BPI ayant également donné son agrément, ce Prêt Garanti par l’Etat (PGE) est en cours de mise en place. Il permettra ainsi d’aborder sereinement la saison 2020 et de sécuriser les approvisionnements de la saison de Noël. Celle-ci verra la sortie de plusieurs innovations que Lexibook présentera dans les prochaines semaines, et...

Continue reading

Scape Technologies sætter igen nye standarder for brugervenlig bin-picking med overlegen stabilitet.

Pressemeddelelse                                                                                          8. juni 2020Scape Technologies sætter igen nye standarder for brugervenlig bin-picking med overlegen stabilitet.Scape Technologies har lanceret en ny simplificeret brugergrænseflade til SCAPE Bin-Picker systemerne. Markedets mest stabile og fleksible bin-picking system er blevet enkelt og let at anvende, uden at der er gået på kompromis med systemets overlegne pålidelighed.Scape Technologies har nu nået en af de væsentligste milepæle, der blev fastlagt i forbindelse med selskabets IPO: Markant optimering af SCAPE Bin-Picker systemets brugervenlighed, der vil minimere den tid og de ressourcer, som kunder og partnere skal bruge på at implementere systemet og omstille til nye emner. Den gennemgribende make-over af brugeroplevelsen er...

Continue reading

SIKA ACQUIRES MARKET LEADER IN ROOFING AND WATERPROOFING SYSTEMS IN EGYPT

SIKA ACQUIRES MARKET LEADER IN ROOFING AND WATERPROOFING SYSTEMS IN EGYPTSika has acquired Modern Waterproofing Group, a leading manufacturer of roofing and waterproofing systems in Egypt. The acquisition supplements and rounds off the product portfolio of Sika Egypt and offers new opportunities for growth in the Egyptian construction market. The acquired business generates annual sales of CHF 26 million.Modern Waterproofing is based in Cairo with a production facility in Badr City which is a logistically ideal location close to Cairo and the New Administrative Capital. It manufactures solutions for the waterproofing and roofing markets, focusing on a comprehensive range of modified bitumen membranes. As complementary products, the company also offers liquid coatings and insulation boards. With its solid reputation as a high-quality company,...

Continue reading

SIKA ÜBERNIMMT FÜHRENDEN ÄGYPTISCHEN HERSTELLER VON ABDICHTUNGSSYSTEMEN FÜR BAUWERKE UND DÄCHER

SIKA ÜBERNIMMT FÜHRENDEN ÄGYPTISCHEN HERSTELLER VON ABDICHTUNGSSYSTEMEN FÜR BAUWERKE UND DÄCHERSika übernimmt die Modern Waterproofing Group, einen führenden ägyptischen Hersteller von Abdichtungssystemen für Bauwerke und Dächer. Die Übernahme ergänzt das Produktportfolio von Sika Egypt und rundet dieses ab. Darüber hinaus eröffnet sie neue Möglichkeiten, um im ägyptischen Baumarkt weiter zu wachsen. Das akquirierte Geschäft erzielt einen Jahresumsatz von CHF 26 Millionen.Modern Waterproofing mit Sitz in Kairo verfügt in Badr City über ein logistisch ideal gelegenes Produktionswerk in der Nähe von Kairo und der neuen Verwaltungshauptstadt. Das Unternehmen stellt Abdichtungssysteme für Bauwerke und Dächer her, wobei der Hauptfokus auf einem umfassenden Sortiment an modifizierten Bitumen-Abdichtungsmembranen liegt. Ergänzend werden auch...

Continue reading

LHV to acquire the Danske Bank’s unit involved with Estonian corporate and public sector credits

AS LHV Pank, a subsidiary of AS LHV Group, and Danske Bank A/S have signed an agreement according to which LHV will acquire Danske Bank’s business unit operating the Estonian corporate and public sector credits, that as at the end of April amounted to approximately 312 million euros.LHV Pank and Danske Bank have reached an agreement on the price of the transaction, according to which a discount of 19 million euros will be subtracted from the volume of the portfolio as calculated at the moment of the transaction. The transaction will be finalised in October of the current year and then the final scope and price of the transaction will also be determined. The volume of the portfolio is anticipated to amount to 280 million euros at the moment of finalising the transaction. The Competition Authority of the Republic of Estonia will have to...

Continue reading

SEB: Boprisindikatorn – Hopp om stabilisering i hushållens boprisförväntningar

SEB:s Boprisindikator ökar med 3 enheter i juni, till minus 23. På regional nivå är det små skillnader och indikatorn ligger i de sex regionerna mellan minus 22 och minus 27. Hushållens förväntningar på reporäntans nivå stiger något och ligger nu på 0,44 procent. Andelen som planerar att binda sina rörliga lån minskar från förra månadens  8 procent till 5 procent.Andelen hushåll som tror på stigande priser minskar med 1 procentenhet jämfört med förra månaden och ligger nu på 20 procent. Andelen hushåll som tror på sjunkande priser det kommande året uppgår nu till 43 procent, att jämföra med 47 procent föregående månad. Andelen som tror på oförändrade priser har ökat med sju enheter och ligger denna månad på 30 procent. Boprisindikatorn är skillnaden mellan andelen som tror på stigande priser och andelen som tror på fallande priser. Indikatorn...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.